Clinical Trial Research Project Articles & Analysis
12 news found
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buffalo. This month, it becomes official, as Dr. Cummings joins the ONY Biotech team as Chief Medical Officer, and the founder of the company and former Chief Medical Officer, Dr. Edmund Egan, steps into the role of Chief Scientific Officer. ...
With entities based in Belgium, France, Spain and the UK, OncoDNA has built an outstanding network of cancer clinicians-researchers across Europe. The company will act as a primary lab partner, operating C2i’s whole-genome sequencing (WGS) and minimal-residual disease (MRD) cancer monitoring platform for European clinical research ...
To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. The Oncomine Clinical Research Grant awards ...
Oxford Brain Diagnostics Ltd, a software company focused on developing diagnostics based on changes in the brain at the cellular level, is delighted to announce that we have established a research collaboration with Principal Investigator Dr Takashi Nakajima, MD, PhD at Niigata Hospital and Dr Kazuo Shigematsu at Minami Kyoto National Hospital. In Japan, clinical MRI scanners are available for ...
Reuth Rehabilitation Hospital and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the hospital’s facility in Tel-Aviv, Israel. ...
Attwill Medical Solutions was proud to host former WI governor and current president of the University of Wisconsin System Tommy Thomson today for a roundtable discussion regarding the potential of the company working with University of Wisconsin System to co-develop technology, conduct clinical research projects, and recruit graduates of the UW System, as well as a factory tour. Attwill is ...
University Hospitals Leuven, KU Leuven and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the university’s facility in Leuven, Belgium. ...
Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies focused on the generation of data that may improve clinical outcomes for patients in the future. As part of an initial pilot focused on oncology, the ...
We are excited to announce the development of a visual genomic data portal to support the University of Utah. The University currently hosts more than 19,000 exomes and 8,000 genomes from over 7,000 different families. This includes data from the Pediatric Cardiac Genomics Consortium (NHLBI), the Undiagnosed Disease Network (NIH), the Sudden Death in the Young Consortium (NHLBI), the American ...
Longenesis joins the 500 Startups family in a 16-week Singapore-based program designed to accelerate the growth of the best-selected startups through deep market insights, hands-on coaching and exposure to 500’s network of partners, experts, and talent. For the next 4 months, our team will be fully immersed in the Singapore market leveraging the 500 Startups’ network to multiply the ...
Do you have senior moments? Are you concerned your memory loss may be a sign of something beyond normal aging? An innovative eye exam is helping physicians answer these questions with confidence. Optina Diagnostics, a world leader in retinal imaging technology and AI with a vision to change mindsets when it comes to brain health and Dr. Jean-Claude Tardif’s research group from the Montreal ...
Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia, to increase understanding of the genomic differences between young and older patients with oral cancer and between progressive and non-progressive oral potentially malignant lesions. Oral cancer is part of a group of cancers commonly ...